NanoEntek, Inc. (039860.KQ)

5,440.00 +200.00 (+3.82%) At close: 03:30PM KST

NanoEntek, Inc.

5, Digital-ro 26-gil
12th Floor Guro-gu
Seoul 08389
South Korea
82 2 6220 7728
https://www.nanoentek.com

Sector(s): 
Industry: 
Full-time employees: 137

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jin-Hyung Park	Chief Exec. Officer and Director	N/A	N/A	1967
Mr. Han-Sang Cho	Sr. Managing Director	N/A	N/A	1967
Mr. Chan-Il Jeong	Sr. Managing Director	N/A	N/A	1969
Mr. Hee-Don An	Managing Director	N/A	N/A	1968
Ms. Sun-Mee Han	Managing Director	N/A	N/A	1973
Mr. Jung-Goo Seo	Vice-Pres and Director	N/A	N/A	1962

Amounts are as of 31 December 2012, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

NanoEnTek Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a quantitative fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, an analytical device for counting the residual white blood cells; ADAMII, a fluorescence stem cell counter; EVE, a benchtop counter to measure cell count and viability; Arthur/fluorescence cell counters; automated somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company was founded in 2000 and is headquartered in Seoul, South Korea.

Corporate governance

NanoEntek, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.